Background illustration for clinical trials search

Paid Clinical Trials Torrance

Discover 3,498 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,498

Featured

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for

Small Cell Lung Cancer

Location: Duarte CA, Irvine CA, Goodyear AZ, Eugene OR,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07365241

Phase 3, Recruiting

Featured

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

for

Acute Myeloid Leukemia

Location: Duarte CA, Houston TX, St Louis MO, Atlanta GA,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07581002

Phase 2, Phase 3, Recruiting

Featured

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

for

Multiple Myeloma

Location: Duarte CA, Irvine CA, Houston TX, Cincinnati OH,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07555938

Phase 3, Recruiting

Featured

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

for

Multiple Myeloma

Location: Duarte CA, Irvine CA, Denver CO, Chicago IL,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07409246

Phase 1, Recruiting

Featured

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

for

Advanced Squamous Tumors

Location: Duarte CA, Irvine CA, Irving TX, Chicago IL,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07241039

Phase 1, Recruiting

Featured

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for

Colorectal Cancer

Location: Duarte CA, Goodyear AZ, Portland OR, Aurora CO,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07525206

Phase 3, Recruiting

Featured

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

for

Neoplasms

Location: Duarte CA, Aurora CO, San Antonio TX, Houston TX,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06884618

Phase 1, Recruiting

Featured

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for

Breast Cancer

Location: Duarte CA, Irvine CA, San Diego CA, La Jolla CA,

Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07100106

Phase 1, Phase 2, Recruiting

Featured

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

for

Ovarian Cancer

Location: Duarte CA, Irvine CA, West Valley City UT, Denver CO,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07278336

Phase 1, Recruiting

Featured

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

for

Alzheimer's Disease

Location: Irvine CA, Boulder CO, Dallas TX, Cordova TN,

Sponsor: AbbVie

Sex: All

Age: 50 - 70+

Code: NCT07599670

Phase 1, Phase 2, Recruiting

Featured

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for

Systemic Lupus Erythematosus, Rheumatoid Arthritis

Location: Tustin CA, Red Oak TX, Jackson TN, Orland Park IL,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase 1, Recruiting

Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

for

Obesity or Overweight

Location: Irvine CA, San Diego CA, Walnut Creek CA, Tucson AZ,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351045

Phase 3, Recruiting

Featured

A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

for

Hepatic Impairment

Location: Lake Forest CA, San Antonio TX, Orlando FL

Sponsor: Genentech, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144111

Phase 1, Recruiting

Featured

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

for

Migraine

Location: Aliso Viejo CA, Grand Island NE, Naperville IL

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07310290

Recruiting

Featured

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

for

Ventral Hernia

Location: Riverside CA, Dallas TX, Rochester MN, Evanston IL,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07226791

Phase 2, Recruiting

Featured

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for

Ulcerative Colitis

Location: Lancaster CA, San Diego CA, Salt Lake City UT,

Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06979336

Phase 2, Recruiting

Active & Responsive

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for

Anatomic Stage I Breast Cancer AJCC v8,

Location: Torrance CA, Los Angeles CA, Beverly Hills CA,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05929768

Phase 3, Recruiting

Active & Responsive

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

for

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Location: Torrance CA, Long Beach CA, Irvine CA, La Mesa CA,

Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT06338995

Phase 3, Recruiting

Active & Responsive

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

for

Diabetes Mellitus, Overweight, Obesity

Location: Lomita CA, Walnut Creek CA, Dallas TX, Houston TX,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07533175

Phase 3, Recruiting

Active & ResponsiveNew

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

for

Overweight, Obesity

Location: Lomita CA, Fullerton CA, Las Vegas NV, Walnut Creek CA,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07720271

Phase 3, Recruiting

Paid Clinical Trials Torrance

Filter results

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

Interested in new trials?

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight